Court rules wholesaler must provide controlled substances to pharmacy

Abstract

Success with drug therapy requires effective collaboration between many individuals and businesses in the lengthy chain of pharmaceutical distribution. But efforts to prevent controlled substance diversion may lead to confrontation rather than collaboration in the acquisition of needed medications. A recent case from Arizona illustrates how courts may be asked to resolve disputes about access to pharmaceutical products.